Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epidemiological profile of atrial fibrillation: a contemporary perspective.

Literature DB >> 16194688

Epidemiological profile of atrial fibrillation: a contemporary perspective.

Teresa S M Tsang¹, Yoko Miyasaka, Marion E Barnes, Bernard J Gersh.

Abstract

Entities: Disease

Mesh：

Year: 2005 PMID： 16194688 DOI： 10.1016/j.pcad.2005.06.001

Source DB: PubMed Journal: Prog Cardiovasc Dis ISSN： 0033-0620 Impact factor: 8.194

Keyword Cloud
Cited

× No keyword cloud information.

21 in total

1. Patients without comorbidities at the time of diagnosis of atrial fibrillation: causes of death during long-term follow-up compared to matched controls.

Authors: Tommy Andersson; Anders Magnuson; Ing-Liss Bryngelsson; Ole Frøbert; Karin M Henriksson; Nils Edvardsson; Dritan Poçi
Journal: Clin Cardiol Date: 2017-08-25 Impact factor: 2.882

Review 2. Rate Versus Rhythm Control Pharmacotherapy For Atrial Fibrillation: Where are We in 2008?

Authors: James A Reiffel
Journal: J Atr Fibrillation Date: 2008-05-16

3. TASK-1 current is inhibited by phosphorylation during human and canine chronic atrial fibrillation.

Authors: Erin Harleton; Alessandra Besana; Parag Chandra; Peter Danilo; Tove S Rosen; Michael R Rosen; Michael Argenziano; Richard B Robinson; Steven J Feinmark
Journal: Am J Physiol Heart Circ Physiol Date: 2014-11-26 Impact factor: 4.733

4. Baseline atrial fibrillation is associated with contrast-induced nephropathy after cardiac catheterization in coronary artery disease: Systemic review and meta-analysis.

Authors: Narut Prasitlumkum; Chanavuth Kanitsoraphan; Veraprapas Kittipibul; Pattara Rattanawong; Pakawat Chongsathidkiet; Wisit Cheungpasitporn
Journal: Clin Cardiol Date: 2018-11-26 Impact factor: 2.882

Epidemiological profile of atrial fibrillation: a contemporary perspective.

1. Patients without comorbidities at the time of diagnosis of atrial fibrillation: causes of death during long-term follow-up compared to matched controls.

Review 2. Rate Versus Rhythm Control Pharmacotherapy For Atrial Fibrillation: Where are We in 2008?

3. TASK-1 current is inhibited by phosphorylation during human and canine chronic atrial fibrillation.

4. Baseline atrial fibrillation is associated with contrast-induced nephropathy after cardiac catheterization in coronary artery disease: Systemic review and meta-analysis.

5. Trends in atrial fibrillation in patients hospitalized with an acute coronary syndrome.

Review 6. Potential use of NOACs in developing countries: pros and cons.

7. Prevalence of early-onset atrial fibrillation in congenital long QT syndrome.

8. Novel pharmacological approaches for antiarrhythmic therapy.

Review 9. Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target.

Review 10. Statin therapy may influence the incidence of postoperative atrial fibrillation: what is the evidence?